IGF1 effects in the kidney are modulated by nitric oxide, and nitric oxide synthase inhibition reduced renal hypertrophy and hyperfiltration in STZ-induced diabetes mellitus rats [137]. This evidence concerns the gene IGF1 and diabetes mellitus.